跳至主要内容
临床试验/NL-OMON52607
NL-OMON52607招募中不适用

Exercise for breast cancer patients undergoing neoadjuvant chemotherapy: the BENEFIT study - BENEFIT

niversitair Medisch Centrum Utrecht0 个研究点目标入组 9 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Unilateral or bilateral primary carcinoma of the breast, confirmed
  • histologically by core biopsy
  • Scheduled for neoadjuvant chemotherapy (but not yet started)
  • Confirmed hormone receptor (HR) and Her2 status
  • Women >= 18 years of age
  • Sufficient Dutch language skills
  • Willing to be randomly assigned to one of the three study arms
  • Signed informed consent

排除标准

  • Any physical or mental conditions that would hamper the performance of the
  • training programs or the completion of the study procedures
  • Engaging in systematic intense exercise training (at least 1h twice per week)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验